fullerene c60 has been researched along with Blood Clot in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bai, X; Chang, YN; Chen, K; Chen, X; Chen, Z; Kong, J; Li, J; Liang, H; Liang, W; Liang, Y; Mao, M; Wang, Y; Xia, S; Xing, G; Zhang, J | 1 |
1 other study(ies) available for fullerene c60 and Blood Clot
Article | Year |
---|---|
Intrinsic Biotaxi Solution Based on Blood Cell Membrane Cloaking Enables Fullerenol Thrombolysis
Topics: Animals; Biocompatible Materials; Cell Survival; Disease Models, Animal; Drug Carriers; Erythrocyte Membrane; Fibrinolysis; Fluorescein; Fullerenes; Hep G2 Cells; Human Umbilical Vein Endothelial Cells; Humans; Nanoparticles; Rats; Silicon Dioxide; Thrombosis; Tissue Distribution; Urokinase-Type Plasminogen Activator | 2020 |